Articles tagged with Type 1 Diabetes
A study by Karolinska Institutet found a clear correlation between elevated blood glucose levels in mothers and the risk of heart defects in their babies. Pregnant women with type 1 diabetes are at a higher risk, especially those with high blood glucose levels during early pregnancy.
Women with well-controlled type 1 diabetes often give birth to babies that are large for their gestational age, despite excellent glycemic control throughout pregnancy. Continuous glucose monitoring revealed elevated fetal weight and abdominal circumference percentages.
A recent study has linked increased risk of autism spectrum disorder (ASD) in children born to mothers with the three main types of diabetes. The research, published in JAMA Network, suggests a higher risk for children exposed in utero to maternal preexisting type 1 diabetes and gestational diabetes diagnosed by 26 weeks.
Long-term follow-up of BCG vaccine trial participants shows significant clinical benefits, including near-normal blood sugar levels, which persist for up to five years. The study reveals a novel metabolic mechanism that increases cellular glucose consumption, leading to improved insulin sensitivity.
A study by McGill University Health Centre found that two-thirds of teenagers and young adults with type 1 diabetes experience stigma, which can lead to neglecting treatment and severe hypoglycemia. The study also highlights the need for social support and resiliency programs to help individuals manage their condition.
A study published in Diabetes Care found that the rapid decline in insulin production associated with Type 1 diabetes follows a two-phase pattern: an initial exponential fall and a subsequent stable phase. This discovery suggests that people with Type 1 diabetes may retain some working beta-cells for seven years after diagnosis.
A study by Joslin Diabetes Center researchers has found a correlation between long-term type 1 diabetes and mild cognitive decline, particularly in memory. The decline is also associated with an increased risk of cardiovascular disease.
Researchers have developed a new approach using synthetic hydrogel particles to educate the immune system to accept transplanted insulin-producing islets. The technique could allow for an 'off-the-shelf' therapy for type 1 diabetes without long-term immune suppression, potentially treating millions of people worldwide.
A survey of patients with type 1 diabetes on a very-low-carbohydrate diet found exceptional blood-sugar control with few complications, including lower rates of hypoglycemia and diabetic ketoacidosis. The researchers call for controlled clinical trials to test the diet's safety and efficacy.
A new study found structural and functional changes in the muscles of young adults with Type 1 diabetes, leading to reduced metabolism and greater difficulty controlling blood glucose levels. The study suggests revising exercise guidelines for those with Type 1 diabetes to prevent muscle damage.
A review of 41 trials involving over 1000 people with type 1 diabetes found that artificial pancreas systems provided almost two and a half extra hours of normal blood glucose levels per day. The treatment also reduced time spent in both hyperglycaemia and hypoglycaemia compared to other types of insulin-based therapy.
A study has found structural and functional changes in muscles of young adults with Type 1 diabetes, leading to reduced metabolism and increased risk of disability.
A new study from McMaster and York universities found structural and functional changes in the power generation parts of the cell, or mitochondria, of those with diabetes. These changes could result in reduced metabolism, greater difficulty controlling blood glucose and accelerated disability development.
A study published in the Endocrine Society's Journal of the Endocrine Society finds higher rates of type 1 diabetes in areas with a high proportion of fast food restaurants and convenience stores. The research suggests that an adverse food environment may contribute to the development of type 1 diabetes, particularly among adults.
Researchers are investigating the impact of antioxidant vitamins C and E, alpha lipoic acid, resveratrol, and Sirt1 on blood vessel health in premenopausal women with type 1 diabetes. Early evidence suggests that treatment may restore protection against cardiovascular disease.
A study found that continuous glucose monitors (CGMs) improve blood glucose control, reduce hypoglycemia episodes, and increase quality of life for patients with type 1 diabetes. The use of CGMs is cost-effective over manual testing with strips, with savings of $3,796 per year.
Children with regular healthcare are less likely to develop life-threatening diabetic ketoacidosis, a complication of type 1 diabetes. Adolescents with a regular family physician or pediatrician have a significantly reduced risk of DKA, highlighting the importance of primary care for children.
A study in mice suggests that protective immune cells forming outside the thymus may defend against autoimmune diabetes. Gut microbes affecting this cell population may also protect against disease.
Researchers calculated genetic scores from over 30 genes in 3000 children with no family history of type 1 diabetes. The upper quartile of scores was associated with a greater than 10% risk for pre-symptomatic stage of multiple islet autoantibodies by age 6.
A Phase 3 clinical trial funded by the National Institute of Allergy and Infectious Diseases found consistent and dramatic improvements in quality of life among participants with type 1 diabetes who had frequent severe hypoglycemia. Islet recipients also reported better overall health status despite needing lifelong treatment.
A new study suggests that providing free insulin and blood glucose test strips to low- and middle-income families in India significantly improves blood-sugar control. The study also found that patients' knowledge of diabetes improved, especially those with higher education and urban dwellings.
Researchers developed a wearable heart rate monitor that detected hypoglycemia using beat-to-beat variation in heart rate. The device showed promise for timely detection of impending hypoglycemia, but requires further refinement to increase accuracy and precision.
A new study by The Endocrine Society shows that an insulin pump system can improve glycemic outcomes in children with type 1 diabetes starting from age 7. The MiniMed 670G system also demonstrates effectiveness in adults and adolescents, leading to significant improvements in time spent within target glucose ranges and reduced A1c levels.
Research analysis of blood mediators in type 1 diabetes and kidney disease patients reveals 10 elevated proteins, with TNF-alpha family and IL-6 significantly impacting 40% of patients. This study suggests personalized medicine approach to target specific inflammatory mediators for effective treatment.
A new classification of diabetes has been discovered, which can predict the risk of serious complications and provide tailored treatment suggestions. The study, published in The Lancet Diabetes & Endocrinology, reveals that type 2 diabetes consists of several subgroups, each with unique characteristics.
Researchers identified five distinct subtypes of type 2 diabetes and one autoimmune type, each with unique characteristics and associated complications. These findings may enable tailored treatment approaches for patients with diabetes, moving towards precision medicine.
Scientists have identified progenitor cells within the human pancreas that can be stimulated to develop into glucose-responsive beta cells. These findings open the door to developing regenerative cell therapies for those living with type 1 diabetes.
Researchers discovered that a common blood pressure medication, methyldopa, can prevent the onset of type 1 diabetes in up to 60% of those at risk by blocking a specific molecule. The study used a supercomputer and found that methyldopa not only blocks the DQ8 molecule but also doesn't harm other immune cells.
Researchers identified six novel chromosomal regions associated with type 1 diabetes, enabling the discovery of more genes that cause the disease. The study also found different genetic markers for early detection of autoantibodies in patients at risk.
A new study found that both type 2 and type 1 diabetes are associated with complications during pregnancy, including stillbirths, emergency Caesarean sections, and infant mortality. The research also found a significant increase in high birth weight and preterm delivery among babies born to mothers with diabetes.
Researchers at Helmholtz Munich successfully halted an autoimmune reaction in the early stages of islet autoimmunity, a key step in developing potential treatments for type 1 diabetes. The study reveals that inhibiting the miRNA181a/NFAT5 axis can increase Treg formation and reduce immune activation.
A recent study found a rapid increase in type 1 diabetes cases among children in China over the past two decades. The majority of new cases are diagnosed in adults, highlighting the need for more resources to improve care for adult-onset type 1 diabetes.
A large-scale international randomized trial showed that weaning to an extensively hydrolyzed casein formula during infancy did not reduce the incidence of type 1 diabetes. The study, TRIGR Study, followed infants for at least 10 years and found no evidence to revise current dietary recommendations.
A large-scale international trial found that modifying baby formula to reduce cow's milk proteins didn't decrease the risk of type 1 diabetes. The study followed 2,159 infants with a family member affected by type 1 diabetes and genetic risk for years to determine which developed diabetes.
A new removable implant has been developed to control type 1 diabetes, with hundreds of thousands of islet cells protected by a thin hydrogel coating and attached to a polymer thread. This therapy could replace daily insulin injections and offer a more effective management solution for the disease.
Researchers have developed tiny bilirubin-filled capsules that can improve the survival rates of transplanted pancreatic islet cells. This breakthrough has implications for treating Type 1 diabetes in both canine and human patients, with a potential treatment program for dogs that could lead to improved treatments for humans.
A new nationwide clinical trial aims to make managing type 1 diabetes easier for patients using the world's first hybrid closed-loop system automated insulin delivery device. The trial, funded by Medtronic, will monitor blood glucose levels and adjust insulin doses continuously to help patients maintain stable blood sugar levels.
Researchers at Seattle Children's are exploring therapies that reprogram T cells to calm down an overactive immune response, which may hold promise for curing type 1 diabetes. The goal is to develop a treatment that could protect new patients from the life-long requirement for insulin therapy.
Research published in the Lancet Diabetes & Endocrinology found that over 40% of type 1 diabetes cases occur after age 30, and many adults are initially misdiagnosed with type 2. Type 1 diabetes requires insulin treatment to control blood sugar levels, while type 2 can often be managed with diet and medication.
A study published in the Journal of Clinical Endocrinology & Metabolism found that continuous glucose monitors can protect against hypoglycemia episodes, even when the body's defense mechanisms are impaired. The devices raised awareness of low blood sugar threats and reduced severe episodes.
A daily insulin pill did not slow down or prevent type 1 diabetes development among individuals with a higher risk of developing the disease. The trial involved 560 participants who received either oral insulin or a placebo, and found that time to diagnosis was not significantly different between groups.
Scientists developed an enterovirus vaccine that protects against virus-induced diabetes in a mouse model for Type 1 diabetes. The study suggests the potential role of enteroviruses in human Type 1 diabetes and offers a new preventative treatment option.
Researchers from Wake Forest Institute for Regenerative Medicine discovered that sodium percarbonate and calcium peroxide improved insulin-producing cell function and viability in lab-built bioartificial pancreas. Oxygen-generating materials could potentially supplement cells' high oxygen needs, aiding in diabetes treatment.
Researchers at Boston Children's Hospital have successfully reversed type 1 diabetes in a mouse model by infusing pre-treated blood stem cells. The treated cells curbed the autoimmune reaction and reversed hyperglycemia in diabetic mice, with almost all mice cured of diabetes in the short term and one third maintaining normal blood sug...
A recent study from UC Davis researchers refutes the use of an anti-malaria drug to create new insulin-producing cells for Type 1 diabetes treatment. The findings highlight the crucial need for reproducibility in scientific research, contradicting a previous report that sparked excitement in the field.
A new study reveals that up to 97.3% of people with pancreatic disease are misdiagnosed with Type 2 diabetes, instead of the correct condition, Type 3c diabetes. This can lead to delayed treatment and devastating long-term effects for patients.
A study found that adequate vitamin D levels during infancy and childhood are associated with a reduced risk of islet autoimmunity, a precursor to type 1 diabetes. Vitamin D status varies by latitude, and higher childhood levels are significantly linked to decreased risk of IA.
A study published in JAMA found that insulin pump therapy among young patients with type 1 diabetes was associated with lower rates of severe hypoglycemia and diabetic ketoacidosis compared to traditional injections. This innovative treatment approach offers improved clinical outcomes for this vulnerable population.
A new study of children from Sweden and Finland found that the swine flu vaccine Pandemrix did not increase the risk of developing autoantibodies against insulin-producing beta cells or type 1 diabetes. In fact, vaccinated children in Finland showed a reduced risk of developing autoantibodies and type 1 diabetes.
A new trial found that continuous glucose monitoring during pregnancy reduces the number of babies born larger than average, need for intensive care, and pre-eclampsia rates. Birth outcomes improved significantly for mothers using the device compared to traditional finger-prick tests.
A global study of over 800 patients with Type 1 diabetes found that dapagliflozin, a Type 2 diabetes medicine, significantly improved blood sugar levels. The results demonstrate the drug's efficacy as an adjunct therapy to insulin, reducing A1C levels by more than 0.5% without severe hypoglycemia.
Research shows that pregnancy outcomes remain poor for women with type 1 diabetes, especially those diagnosed at a young age. The study found higher rates of pre-eclampsia, stillbirth, and low birth weight among mothers with childhood-onset T1D.
A new biomarker, LRG1, can predict the occurrence of pre-eclampsia in pregnant women with type 1 diabetes, increasing their risk by 4 times. The study found that LRG1 levels were significantly higher in women who developed PE compared to those who did not.
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes. Patients experienced a lower rate of confirmed severe hypoglycemia than observed in patients on placebo and also had weight loss.
Researchers developed a novel antibody detection technology that increases the sensitivity of Type 1 Diabetes tests, enabling screening for more autoimmune antibodies implicated in the disease. The technology holds promise for making populationwide screening practical and catching the disease earlier.
A nationwide Norwegian study found that H1N1 infected individuals, especially children under 15, were twice as likely to develop type 1 diabetes than the general population. Infection with H1N1 influenza virus was linked to a doubled risk of T1D in Norwegians aged 30 or younger.
A new study suggests that specific genetic variants increase the risk of developing type 1 diabetes in later life, including after the age of 30. The research found that individuals with certain HLA genotypes have a higher likelihood of developing late-onset T1D and being diagnosed at an older age.
Regulatory T-cells in adipose tissue increase in response to environmental stimuli, promoting heat production and fatty acid breakdown. This discovery highlights the complex interactions between immune cells and environment in maintaining metabolic balance.
Researchers at Westmead Institute for Medical Research have discovered a new approach to treating type 1 diabetes, using pancreatic islet transplants delivered into the quadriceps muscle. This method presents fewer risks than current clinical practice of transplanting islets into the liver via the portal vein.
Research in mice shows that gut bacteria play a crucial role in modulating the effects of a powerful protective gene against type 1 diabetes. The findings highlight the importance of early environmental exposures to a variety of germs in proper immune system development.